Matrabasti in Management of Benign Prostatic Hyperplasia

A Clinical Study of Tilvaka Ghrita Matrabasti in the Management of Benign Prostatic Hyperplasia

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/07/020260

Enrollment

Registered

2019-07-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: Matra basti: Matra basti with tilvaka ghrita 7 days once in a day Control Intervention1: Not Applicable: Not Applicable

Eligibility

Inclusion criteria

Inclusion criteria: Patient having classical sign and symptoms of BPH and Radiologicaly diagnosed patient of BPH

Exclusion criteria

Exclusion criteria: Patient suffering from malignancy, congenital deformities of Urogenital tract or any other pelvic pathology, Uncontrolled hypertension Tuberculosis Paralysis Parkisonism etc

Design outcomes

Primary

Measure	Time frame
Symptomatic reliefTimepoint: 7 Days	—

Secondary

Measure	Time frame
Size reduction of ProstateTimepoint: 1 month	—

Countries

India

Contacts

Public ContactKrishna Patel

Parul Institute of Ayurveda

drmukunddhule@gmail.com8379017299

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026